Preoperative Radiation Therapy with Concurrent Capecitabine, Bevacizumab and Erlotinib for Rectal Cancer: A Phase I Trial

This phase I trial evaluated preoperative radiotherapy with concurrent capecitabine, bevacizumab and erlotinib for rectal cancer. Eighteen patients were evaluable. Treatment was well tolerated, and the maximum tolerated dose (MTD) was not reached. One patient had grade 3 acute toxicity and 3 patient...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Radiat Oncol Biol Phys
Autori principali: Das, Prajnan, Eng, Cathy, Rodriguez-Bigas, Miguel A., Chang, George J., Skibber, John M., You, Y. Nancy, Maru, Dipen M., Munsell, Mark F., Clemons, Marilyn V, Kopetz, Scott E., Garrett, Christopher R., Shureiqi, Imad, Delclos, Marc E., Krishnan, Sunil, Crane, Christopher H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5592790/
https://ncbi.nlm.nih.gov/pubmed/24315563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2013.10.034
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi